Raj K. Puri

22.4k total citations · 3 hit papers
289 papers, 15.1k citations indexed

About

Raj K. Puri is a scholar working on Immunology, Biotechnology and Molecular Biology. According to data from OpenAlex, Raj K. Puri has authored 289 papers receiving a total of 15.1k indexed citations (citations by other indexed papers that have themselves been cited), including 183 papers in Immunology, 80 papers in Biotechnology and 64 papers in Molecular Biology. Recurrent topics in Raj K. Puri's work include Toxin Mechanisms and Immunotoxins (149 papers), Transgenic Plants and Applications (68 papers) and Monoclonal and Polyclonal Antibodies Research (59 papers). Raj K. Puri is often cited by papers focused on Toxin Mechanisms and Immunotoxins (149 papers), Transgenic Plants and Applications (68 papers) and Monoclonal and Polyclonal Antibodies Research (59 papers). Raj K. Puri collaborates with scholars based in United States, Japan and Thailand. Raj K. Puri's co-authors include Bharat Joshi, Koji Kawakami, Syed R. Husain, Nicholas I. Obiri, Pamela Leland, Takashi Murata, Waldemar Debinski, Ira Pastan, Jay P. Siegel and Mariko Kawakami and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Raj K. Puri

286 papers receiving 14.8k citations

Hit Papers

3 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

IL-13 signaling through the IL-13α2 receptor is involved in induction of TGF-β1 production and fibrosis

2005 716 citations Stefan Fichtner‐Feigl, Warren Strober et al. profile →
Interleukin-2 Receptor γ Chain: a Functional Component of the Interleukin-4 Receptor

1993 522 citations Pamela Leland, Raj K. Puri et al. profile →
MSC-Based Product Characterization for Clinical Trials: An FDA Perspective

2014 370 citations Raj K. Puri et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Raj K. Puri United States	67	7.3k	4.6k	3.6k	1.9k	1.9k	289	15.1k
Douglas T. Fearon United States	76	15.2k 2.1×	5.4k 1.2×	6.6k 1.8×	1.8k 0.9×	2.7k 1.4×	178	24.5k
Mario P. Colombo Italy	79	15.1k 2.1×	7.6k 1.6×	8.5k 2.3×	880 0.5×	1.0k 0.5×	355	24.2k
Hiroshi Shiku Japan	64	6.6k 0.9×	6.7k 1.4×	4.4k 1.2×	926 0.5×	1.4k 0.7×	535	16.3k
Robert S. Negrin United States	71	10.2k 1.4×	3.3k 0.7×	6.0k 1.7×	1.9k 1.0×	856 0.4×	307	18.0k
D Metcalf Australia	77	9.3k 1.3×	6.3k 1.4×	5.4k 1.5×	2.0k 1.0×	1.4k 0.7×	274	21.1k
Keith L. Knutson United States	55	6.7k 0.9×	4.7k 1.0×	6.4k 1.8×	2.2k 1.1×	1.6k 0.9×	187	14.3k
Steven T. Pals Netherlands	71	6.2k 0.8×	9.6k 2.1×	5.0k 1.4×	2.1k 1.1×	1.3k 0.7×	238	20.9k
Kevin C. Gatter United Kingdom	88	3.6k 0.5×	12.7k 2.8×	8.2k 2.3×	2.1k 1.1×	1.5k 0.8×	311	26.8k
Glenn Dranoff United States	76	15.7k 2.1×	6.7k 1.4×	12.4k 3.4×	1.3k 0.7×	1.3k 0.7×	188	25.4k
Dale L. Greiner United States	76	9.6k 1.3×	6.1k 1.3×	4.0k 1.1×	1.0k 0.5×	614 0.3×	363	22.6k

Countries citing papers authored by Raj K. Puri

Since Specialization

Citations

This map shows the geographic impact of Raj K. Puri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raj K. Puri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raj K. Puri more than expected).

Fields of papers citing papers by Raj K. Puri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raj K. Puri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raj K. Puri. The network helps show where Raj K. Puri may publish in the future.

Co-authorship network of co-authors of Raj K. Puri

This figure shows the co-authorship network connecting the top 25 collaborators of Raj K. Puri. A scholar is included among the top collaborators of Raj K. Puri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raj K. Puri. Raj K. Puri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Husain, Syed R., Yoshikazu Ohya, & Raj K. Puri. (2017). Current Status and Challenges of Three-Dimensional Modeling and Printing of Tissues and Organs. Tissue Engineering Part A. 23(11-12). 471–473. 8 indexed citations

Suzuki, Akiko, Pamela Leland, Bharat Joshi, & Raj K. Puri. (2015). Targeting of IL-4 and IL-13 receptors for cancer therapy. Cytokine. 75(1). 79–88. 184 indexed citations

Fuss, Ivan J., Bharat Joshi, Zhiqiong Yang, et al.. (2014). IL-13Rα2-bearing, type II NKT cells reactive to sulfatide self-antigen populate the mucosa of ulcerative colitis. Gut. 63(11). 1728–1736. 65 indexed citations

Husain, Syed R., Yoshikazu Ohya, Junya Toguchida, & Raj K. Puri. (2014). Current Status of Multipotent Mesenchymal Stromal Cells. Tissue Engineering Part B Reviews. 20(3). 189–189. 3 indexed citations

Bekisz, Joseph, et al.. (2013). Immunomodulatory Effects of Interferons in Malignancies. Journal of Interferon & Cytokine Research. 33(4). 154–161. 40 indexed citations

Jain, Meenu, Lisa Zhang, Mei He, et al.. (2012). Interleukin‐13 receptor alpha2 is a novel therapeutic target for human adrenocortical carcinoma. Cancer. 118(22). 5698–5708. 25 indexed citations

Yang, Liying, Tomohisa Horibe, Masayuki Kohno, et al.. (2011). Targeting Interleukin-4 Receptor α with Hybrid Peptide for Effective Cancer Therapy. Molecular Cancer Therapeutics. 11(1). 235–243. 33 indexed citations

Shimamura, Takeshi, Toshio Fujisawa, Syed R. Husain, Bharat Joshi, & Raj K. Puri. (2010). Interleukin 13 Mediates Signal Transduction through Interleukin 13 Receptor α2 in Pancreatic Ductal Adenocarcinoma: Role of IL-13 Pseudomonas Exotoxin in Pancreatic Cancer Therapy. Clinical Cancer Research. 16(2). 577–586. 41 indexed citations

Fujisawa, Toshio, Bharat Joshi, Atsushi Nakajima, & Raj K. Puri. (2009). A Novel Role of Interleukin-13 Receptor α2 in Pancreatic Cancer Invasion and Metastasis. Cancer Research. 69(22). 8678–8685. 113 indexed citations

10.

Joshi, Bharat, Pamela Leland, Alfonso Calvo, Jeffrey E. Green, & Raj K. Puri. (2008). Human Adrenomedullin Up-regulates Interleukin-13 Receptor α2 Chain in Prostate Cancer In vitro and In vivo : A Novel Approach to Sensitize Prostate Cancer to Anticancer Therapy. Cancer Research. 68(22). 9311–9317. 16 indexed citations

11.

Vogelbaum, Michael A., John H. Sampson, Sandeep Kunwar, et al.. (2007). CONVECTION-ENHANCED DELIVERY OF CINTREDEKIN BESUDOTOX (INTERLEUKIN-13-PE38QQR) FOLLOWED BY RADIATION THERAPY WITH AND WITHOUT TEMOZOLOMIDE IN NEWLY DIAGNOSED MALIGNANT GLIOMAS. Neurosurgery. 61(5). 1031–1038. 112 indexed citations

12.

Sampson, John H., Martin Brady, Neil A. Petry, et al.. (2007). INTRACEREBRAL INFUSATE DISTRIBUTION BY CONVECTION-ENHANCED DELIVERY IN HUMANS WITH MALIGNANT GLIOMAS. Operative Neurosurgery. 60(2). 89–99. 112 indexed citations

13.

Player, Audrey, Yonghong Wang, Bhaskar Bhattacharya, et al.. (2006). Comparisons between Transcriptional Regulation and RNA Expression in Human Embryonic Stem Cell Lines. Stem Cells and Development. 15(3). 315–323. 29 indexed citations

14.

Yang, Amy, Josef Mejido, Yongquan Luo, et al.. (2005). Development of a Focused Microarray to Assess Human Embryonic Stem Cell Differentiation. Stem Cells and Development. 14(3). 270–284. 23 indexed citations

15.

Jong, Mariska C. de, George L. Scheffer, Henk J. Broxterman, et al.. (2003). Multidrug-resistant tumor cells remain sensitive to a recombinant interleukin-4-Pseudomonas exotoxin, except when overexpressing the multidrug resistance protein MRP1.. PubMed. 9(13). 5009–17. 8 indexed citations

16.

Kawakami, Mariko, Koji Kawakami, Richard A. Maki, et al.. (2002). Interleukin 4 receptor on human lung cancer: a molecular target for cytotoxin therapy.. PubMed. 8(11). 3503–11. 53 indexed citations

17.

Debinski, Waldemar, Nicholas I. Obiri, Ira Pastan, & Raj K. Puri. (1995). A Novel Chimeric Protein Composed of Interleukin 13 and Pseudomonas Exotoxin Is Highly Cytotoxic to Human Carcinoma Cells Expressing Receptors for Interleukin 13 and Interleukin 4. Journal of Biological Chemistry. 270(28). 16775–16780. 183 indexed citations

18.

Obiri, Nicholas I., et al.. (1993). Expression of high affinity interleukin-4 receptors on human renal cell carcinoma cells and inhibition of tumor cell growth in vitro by interleukin-4.. Journal of Clinical Investigation. 91(1). 88–93. 153 indexed citations

19.

Puri, Raj K., et al.. (1980). Progesterone nuclear receptors in different parts of rabbit Fallopian tube and uterus during ovum transport.. Indian Journal of Experimental Biology. 18(6). 553–556. 5 indexed citations

20.

Puri, Raj K., et al.. (1980). Cyclic AMP levels in different parts of rabbit Fallopian tube and uterus during ovum transport.. Indian Journal of Experimental Biology. 18(2). 154–156. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact